1,2-cyclohexanediamine has been researched along with Liver Neoplasms in 2 studies
1,2-cyclohexanediamine: RN given refers to cpd without isomeric designation
Liver Neoplasms: Tumors or cancer of the LIVER.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sun, Y | 1 |
| Yin, R | 1 |
| Gou, S | 1 |
| Yu, CW | 1 |
| Li, KK | 1 |
| Pang, SK | 1 |
| Au-Yeung, SC | 1 |
| Ho, YP | 1 |
2 other studies available for 1,2-cyclohexanediamine and Liver Neoplasms
| Article | Year |
|---|---|
Antitumor platinum(II) complexes of N-monoalkyl-1R, 2R-diaminocyclohexane derivatives with alkyl groups as hindrance.
Topics: Animals; Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Cell Proliferation; Colorectal | 2012 |
Anticancer activity of a series of platinum complexes integrating demethylcantharidin with isomers of 1,2-diaminocyclohexane.
Topics: Antineoplastic Agents; Apoptosis; Cantharidin; Carboplatin; Carcinoma, Hepatocellular; Cell Cycle; C | 2006 |